Young Human PRP Promotes the Rejuvenation of Aged Bone Marrow Mesen -Chymal Stem Cells and the Therapeutic Effect on Ischemic Heart Disease

Scientists compared the differences between platelet-rich plasma (PRP)-derived from young and aged donors, and to investigate whether it was possible to enhance the viability of elderly human bone marrow MSCs (hBMSCs) using PRP, and to apply the rejuvenated hBMSCs for the treatment of ischemia.